Date Filed | Type | Description |
08/11/2023 |
8-K
| Quarterly results |
06/02/2023 |
8-K
| Other Events Interactive Data |
05/12/2023 |
8-K
| Material Modifications to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Yea... |
05/11/2023 |
8-K
| Quarterly results |
03/23/2023 |
8-K
| Quarterly results |
12/22/2022 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
12/09/2022 |
8-K
| Quarterly results |
12/02/2022 |
8-K
| Quarterly results |
11/10/2022 |
8-K
| Quarterly results |
10/12/2022 |
8-K
| Unregistered Sales of Equity Securities Interactive Data |
08/12/2022 |
8-K
| Quarterly results |
07/07/2022 |
8-K
| Quarterly results |
06/06/2022 |
8-K
| Quarterly results |
04/27/2022 |
8-K
| Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Unregistered Sales of Equity ... |
03/23/2022 |
8-K
| Quarterly results |
12/09/2021 |
8-K
| Quarterly results |
11/19/2021 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits Interactive Data |
11/16/2021 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits Interactive Data |
11/12/2021 |
8-K
| Quarterly results |
10/15/2021 |
8-K
| Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement Interactive Data |
09/13/2021 |
8-K
| Quarterly results |
07/16/2021 |
8-K
| Resignation/termination of a director |
05/12/2021 |
8-K
| Quarterly results |
03/17/2021 |
8-K
| Quarterly results |
01/19/2021 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits |
12/16/2020 |
8-K
| Other Events |
12/14/2020 |
8-K
| Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
Docs:
|
"Opinion of Westward Law, LLC",
"Engagement Letter between Xenetic Biosciences, Inc. and H.C. Wainwright & Co., LLC",
"Form of Securities Purchase Agreement between Xenetic Biosciences, Inc. and the purchasers named therein",
"Xenetic Biosciences, Inc. Announces $6.0 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules",
"Xenetic Biosciences, Inc. Announces Closing of $6.0 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules" |
|
12/09/2020 |
8-K
| Submission of Matters to a Vote of Security Holders |
11/13/2020 |
8-K
| Quarterly results |
10/30/2020 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing |
08/13/2020 |
8-K
| Quarterly results |
06/24/2020 |
8-K
| Quarterly results |
06/16/2020 |
8-K
| Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits |
05/19/2020 |
8-K
| Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits |
|